Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Kidney Clearance of Secretory Solutes Is Associated with Progression of CKD: The CRIC Study.

Chen Y, Zelnick LR, Wang K, Hoofnagle AN, Becker JO, Hsu CY, Feldman HI, Mehta RC, Lash JP, Waikar SS, Shafi T, Seliger SL, Shlipak MG, Rahman M, Kestenbaum BR; CRIC Study Investigators.

J Am Soc Nephrol. 2020 Apr;31(4):817-827. doi: 10.1681/ASN.2019080811. Epub 2020 Mar 23.

PMID:
32205410
2.

Serum Calcification Propensity and Clinical Events in CKD.

Bundy JD, Cai X, Mehta RC, Scialla JJ, de Boer IH, Hsu CY, Go AS, Dobre MA, Chen J, Rao PS, Leonard MB, Lash JP, Block GA, Townsend RR, Feldman HI, Smith ER, Pasch A, Isakova T; CRIC Study Investigators.

Clin J Am Soc Nephrol. 2019 Nov 7;14(11):1562-1571. doi: 10.2215/CJN.04710419. Epub 2019 Oct 28.

PMID:
31658949
3.

Clinical Efficacy of a Novel Two-Part Skincare System on Pollution-Induced Skin Damage.

Makino ET, Jain A, Tan P, Nguyen A, Moga A, Charmel C, Kadoya K, Cheng T, Mehta RC.

J Drugs Dermatol. 2018 Sep 1;17(9):975-981.

PMID:
30235385
4.

Addressing Male Facial Skin Concerns: Clinical Efficacy of a Topical Skincare Treatment Product for Men.

Makino ET, Jiang LI, Tan P, Cheng T, Mehta RC.

J Drugs Dermatol. 2018 Mar 1;17(3):301-306.

PMID:
29537448
5.

Optimizing Facial Rejuvenation with a Combination of a Novel Topical Serum and Injectable Procedure to Increase Patient Outcomes and Satisfaction.

Fabi SG, Zaleski-Larsen L, Bolton J, Mehta RC, Makino ET.

J Clin Aesthet Dermatol. 2017 Dec;10(12):14-18. Epub 2017 Dec 1.

6.

Upregulation of Extracellular Matrix Genes Corroborates Clinical Efcacy of Human Fibroblast-Derived Growth Factors in Skin Rejuvenation.

Kadoya K, Makino ET, Jiang LI, Bachelor M, Chung R, Tan P, Cheng T, Naughton GK, Mehta RC.

J Drugs Dermatol. 2017 Dec 1;16(12):1190-1196.

PMID:
29240854
7.

Clinical Assessment of Immediate and Long-Term Effects of a Two-Step Topical Hyaluronic Acid Lip Treatment.

Makino ET, Tan P, Qian K, Babcock M, Mehta RC.

J Drugs Dermatol. 2017 Apr 1;16(4):366-371.

PMID:
28403271
8.

Combination of In-Office Chemical Peels With a Topical Comprehensive Pigmentation Control Product in Skin of Color Subjects With Facial Hyperpigmentation.

Downie J, Schneider K, Goberdhan L, Makino ET, Mehta RC.

J Drugs Dermatol. 2017 Apr 1;16(4):301-306.

PMID:
28403262
9.

Development and Clinical Assessment of a Comprehensive Product for Pigmentation Control in Multiple Ethnic Populations.

Makino ET, Kadoya K, Sigler ML, Hino PD, Mehta RC.

J Drugs Dermatol. 2016 Dec 1;15(12):1562-1570.

PMID:
28095579
10.

Rejuvenating Hydrator: Restoring Epidermal Hyaluronic Acid Homeostasis With Instant Benefits.

Narurkar VA, Fabi SG, Bucay VW, Tedaldi R, Downie JB, Zeichner JA, Butterwick K, Taub A, Kadoya K, Makino ET, Mehta RC, Vega VL.

J Drugs Dermatol. 2016 Jan;15(1 Suppl 2):s24-37.

PMID:
26741392
11.

Long-term Multi-product Facial Regimen in Subjects with Moderate-to-severe Photodamage and Hyperpigmentation.

Herndon JH, Makino ET, Jiang LI, Stephens TJ, Mehta RC.

J Clin Aesthet Dermatol. 2015 Aug;8(8):16-21.

12.

LEUKEMIC OPTIC NERVE INFILTRATION IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA.

Nagpal MP, Mehrotra NS, Mehta RC, Shukla CK.

Retin Cases Brief Rep. 2016 Spring;10(2):127-30. doi: 10.1097/ICB.0000000000000187.

PMID:
26267525
13.

Total Defense + Repair: A Novel Concept in Solar Protection and Skin Rejuvenation.

McDaniel DH, Hamzavi IH, Zeichner JA, Fabi SG, Bucay VW, Harper JC, Comstock JA, Makino ET, Mehta RC, Vega VL.

J Drugs Dermatol. 2015 Jul;14(7):s3-11.

PMID:
26151795
14.

A technique to prevent overfilling of viewing chamber of intravenous infusion kit.

Kakani L, Sharma SM, Mehta RC, Singh G.

Indian J Anaesth. 2014 Nov-Dec;58(6):780-1. doi: 10.4103/0019-5049.147185. No abstract available.

16.

Hydroquinone-free Skin Brightener System for the Treatment of Moderate-to-severe Facial Hyperpigmentation.

Herndon JH Jr, Makino ET, Stephens TJ, Mehta RC.

J Clin Aesthet Dermatol. 2014 May;7(5):27-31.

17.

Assessment of a superficial chemical peel combined with a multimodal, hydroquinone-free skin brightener using in vivo reflectance confocal microscopy.

Goberdhan LT, Mehta RC, Aguilar C, Makino ET, Colvan L.

J Drugs Dermatol. 2013 Mar;12(3):S38-41.

PMID:
23545932
18.

Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone.

Makino ET, Mehta RC, Garruto J, Gotz V, Sigler ML, Herndon JH.

J Drugs Dermatol. 2013 Mar;12(3):s21-6.

PMID:
23545929
19.
20.

Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone.

Makino ET, Herndon JH, Sigler ML, Gotz V, Garruto J, Mehta RC.

J Drugs Dermatol. 2012 Dec;11(12):1478-82.

PMID:
23377519
21.

Efficacy of a novel treatment serum in the improvement of photodamaged skin.

Sonti S, Makino ET, Garruto JA, Gruber JV, Rao S, Mehta RC.

Int J Cosmet Sci. 2013 Apr;35(2):156-62. doi: 10.1111/ics.12018. Epub 2012 Dec 5.

22.

Combination of physiologically balanced growth factors with antioxidants for reversal of facial photodamage.

Atkin DH, Trookman NS, Rizer RL, Schreck LE, Ho ET, Gotz V, Ford RO, Mehta RC.

J Cosmet Laser Ther. 2010 Feb;12(1):14-20. doi: 10.3109/14764170903449786.

PMID:
20085451
23.

Topically applied physiologically balanced growth factors: a new paradigm of skin rejuvenation.

Sundaram H, Mehta RC, Norine JA, Kircik L, Cook-Bolden FE, Atkin DH, Werschler PW, Fitzpatrick RE.

J Drugs Dermatol. 2009 May;8(5 Suppl Skin Rejuenation):4-13. Review.

PMID:
19562882
24.

Reduction in facial photodamage by a topical growth factor product.

Mehta RC, Smith SR, Grove GL, Ford RO, Canfield W, Donofrio LM, Flynn TC, Leyden JJ.

J Drugs Dermatol. 2008 Sep;7(9):864-71.

PMID:
19112801
25.

Endogenous growth factors as cosmeceuticals.

Mehta RC, Fitzpatrick RE.

Dermatol Ther. 2007 Sep-Oct;20(5):350-9. Review.

PMID:
18045360
26.

1-Benzyl-1,2,3,4-tetrahydroisoquinoline-6,7-diols as novel affinity and photoaffinity probes for beta-adrenoceptor subtypes.

Nikulin VI, Rakov IM, De Los Angeles JE, Mehta RC, Boyd LY, Feller DR, Miller DD.

Bioorg Med Chem. 2006 Mar 15;14(6):1684-97. Epub 2006 Jan 20.

PMID:
16431119
27.

Spectrum of angiographic findings in aortoarteritis.

Rathod KR, Deshmukh HL, Garg AI, Mehta RC, Rachewad SS.

Clin Radiol. 2005 Jul;60(7):746-55.

PMID:
15978884
28.

Peroxide-mediated desulfurization of phosphorothioate oligonucleotides and its prevention.

Krotz AH, Mehta RC, Hardee GE.

J Pharm Sci. 2005 Feb;94(2):341-52.

PMID:
15614814
29.

Intercellular adhesion molecule-1 suppression in skin by topical delivery of anti-sense oligonucleotides.

Mehta RC, Stecker KK, Cooper SR, Templin MV, Tsai YJ, Condon TP, Bennett CF, Hardee GE.

J Invest Dermatol. 2000 Nov;115(5):805-12.

30.

Permeability of antisense oligonucleotide through porcine buccal mucosa.

Jasti BR, Zhou S, Mehta RC, Li X.

Int J Pharm. 2000 Nov 4;208(1-2):35-9.

PMID:
11064209
31.

Biochemical and functional characterization of 1-benzyl substituted trimetoquinol affinity analogs on rat and human beta-adrenoceptors.

Mehta RC, Salazar-Bookaman MM, Fertel RH, De Los Angeles J, Nikulin VI, Fraundorfer PF, Miller DD, Feller DR.

Biochem Pharmacol. 2000 Mar 1;59(5):517-29.

PMID:
10660118
32.
33.
34.

Effect of processing parameters on the properties of peptide-containing PLGA microspheres.

Jeyanthi R, Mehta RC, Thanoo BC, DeLuca PP.

J Microencapsul. 1997 Mar-Apr;14(2):163-74.

PMID:
9132468
35.

Magnetization transfer magnetic resonance imaging: a clinical review.

Mehta RC, Pike GB, Enzmann DR.

Top Magn Reson Imaging. 1996 Aug;8(4):214-30. Review.

PMID:
8870180
36.
37.

Interaction of recombinant human bone morphogenetic protein-2 with poly(d,l lactide-co-glycolide) microspheres.

Duggirala SS, Mehta RC, DeLuca PP.

Pharm Dev Technol. 1996 Apr;1(1):11-9.

PMID:
9552326
38.

A comparison of the skeletal effects of intermittent and continuous administration of calcitonin in ovariectomized rats.

Li M, Shen Y, Burton KW, DeLuca PP, Mehta RC, Baumann BD, Wronski TJ.

Bone. 1996 Apr;18(4):375-80.

PMID:
8726397
39.

Biodegradable indium-111 labeled microspheres for in vivo evaluation of distribution and elimination.

Thanoo BC, Doll WJ, Mehta RC, Digenis GA, DeLuca PP.

Pharm Res. 1995 Dec;12(12):2060-4.

PMID:
8786990
40.

Magnetization transfer MR of the normal adult brain.

Mehta RC, Pike GB, Enzmann DR.

AJNR Am J Neuroradiol. 1995 Nov-Dec;16(10):2085-91.

41.

Improved detection of enhancing and nonenhancing lesions of multiple sclerosis with magnetization transfer.

Mehta RC, Pike GB, Enzmann DR.

AJNR Am J Neuroradiol. 1995 Oct;16(9):1771-8.

42.

Adsorption of salmon calcitonin to PLGA microspheres.

Calis S, Jeyanthi R, Tsai T, Mehta RC, DeLuca PP.

Pharm Res. 1995 Jul;12(7):1072-6.

PMID:
7494805
43.
44.
45.

Aicardi's syndrome: MR appearance of unusual orbital and ventricular cystic lesions.

Mehta RC, Marks MP, Levin PS.

AJR Am J Roentgenol. 1993 Mar;160(3):601-3. No abstract available.

PMID:
8430563
46.

Sustained bronchodilation with isoproterenol poly(glycolide-co-lactide) microspheres.

Lai YL, Mehta RC, Thacker AA, Yoo SD, McNamara PJ, DeLuca PP.

Pharm Res. 1993 Jan;10(1):119-25.

PMID:
8430048
47.

In vivo evaluation of biodegradable progesterone microspheres in mares.

Gupta PK, Mehta RC, Douglas RH, DeLuca PP.

Pharm Res. 1992 Nov;9(11):1502-6. No abstract available.

PMID:
1475240
48.

Fat emulsion particle-size distribution in total nutrient admixtures.

Mehta RC, Head LF, Hazrati AM, Parr M, Rapp RP, DeLuca PP.

Am J Hosp Pharm. 1992 Nov;49(11):2749-55.

PMID:
1471641
49.

Physiologic imaging of the brain.

Mehta RC, Marks MP.

Curr Opin Radiol. 1992 Feb;4(1):95-100. Review.

PMID:
1739606
50.

Skeletal effects of calcitonin in ovariectomized rats.

Wronski TJ, Yen CF, Burton KW, Mehta RC, Newman PS, Soltis EE, DeLuca PP.

Endocrinology. 1991 Oct;129(4):2246-50.

PMID:
1915104

Supplemental Content

Loading ...
Support Center